Anxiety
Conditions
Interventions
Pregnant women in the municipality will be screened, and those who meet the inclusion criteria will be invited to participate in the study. After assessments of anxiety, quality of life, fear of covid
E02.190.204
Sponsors
Universidade Estadual de Montes Claros
Universidade Estadual de Montes Claros
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Pregnant women over 18 years old; up to the gestational age of 37 weeks; availability of time for treatment; and clinically relevant anxiety.
Exclusion criteria
Exclusion criteria: Pregnant women using benzodiazepines, antidepressants or anxiolytics; in treatment with energy therapies or performed them in the last three months; infection, inflammation or injury to the pinna; microporous tape allergy; use of piercing at the insertion site of the devices; anatomical alteration in the hearing aid; missing in more than two consecutive sessions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety reduction, assessed using the State-Trait Anxiety Inventory (STAI). The same classifies anxiety as mild (20 to 40 points), moderate (40 to 60 points), and high (60 to 80 points). The evaluation will be carried out in the first and fourth session, in addition to the 30-day follow-up. The intervention is intended to reduce moderate to high scores. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcome 1. Quality of life will be assessed using the World Health Organization Quality of Life-Bref (WHOQOL-Bref). The instrument has 26 questions, which assess the individual's physical and mental health through 24 questions that encompass the physical, social, psychological and environmental domains, in addition to 2 questions about the perception of quality of life and satisfaction with health. The intervention is intended to increase the scores obtained in the initial assessment. The questionnaire will be applied in the first and fourth session and in the follow-up.;Secondary outcome 2. Fear of covid-19 in the perinatal period will be measured by the COVID-19 Fear Scale in the Perinatal Period (EMC19-9). It is self-completed and has nine items with 5-point Likert scale responses, from “strongly disagree” to “strongly agree”. It is intended that there is a reduction in the total sum after the intervention. The scale will be applied in the first and fourth session and in the follow-up period. | — |
Countries
Brazil
Contacts
Public ContactHerica Correa
Universidade Estadual de Montes Claros
Outcome results
None listed